RxDoctor Payments Data

Murad Alam, MD

MOHS-Micrographic Surgery · Chicago, ILNPI 1578553822

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Merz North America, Inc. at 55.3% of the total. Reporting peaked in 2024 at $566 and has fallen 94.3% since, to $33 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in IL, where the typical reported total is $1,595.

$1,066in general payments, 2019–2025

Across 13 payments — averaging $81.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz North America, Inc.$589
  • AbbVie$365
  • Smith+Nephew$49
  • Acera Surgical, Inc.$47
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$16
$6,252in research payments, 2019–2025

Across 4 payments — averaging $1562.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$6K

What the payments were for

  • Food & beverage$1,066100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,066 in reported general payments places this provider in the 40th percentile of 40 mohs-micrographic surgery providers in Illinois.

See all mohs-micrographic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$1,823,397
Medicare patients
1,208
Services billed
7,857

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate562$3,767
Minocycline Hcl254$1,904
Gentamicin Sulfate47$1,517
Ketoconazole67$1,030
Imiquimod23$728
Fluocinonide18$701
Mupirocin83$576
Triamcinolone Acetonide55$403
Clindamycin Phosphate11$371
Clobetasol Propionate18$292
Clotrimazole18$290
ValacyclovirValacyclovir Hcl11$204
Cephalexin20$163
Finasteride15$124
Hydrocortisone29$88

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →